Our clinical studies have established that impaired alveolar epithelial fluid clearance is associated with a higher mortality in patients with acute lung injury. New studies are needed to understand the biological and clinical mechanisms that impair alveolar epithelial fluid clearance in patients with acute lung injury. It is also important to test therapeutic strategies that may increase the clearance of alveolar edema fluid in the human lung. Therefore, in Aim 1, we will use pulmonary edema fluid and plasma collected from critically ill patients with acute lung injury to study the mechanisms that mediate an increase in protein permeability and a decrease in vectorial fluid transport across cultured human alveolar epithelial type II cells that form tight monolayers in transwell filters grown in an air-liquid interface. Control studies will be done with pulmonary edema fluid and plasma from patients with hydrostatic, cardiogenic pulmonary edema.
In Aim 2, we will collect sequential samples of pulmonary edema fluid and plasma from patients with early acute lung injury to (1) measure alveolar fluid clearance, (2) biological markers of lung epithelial and endothelial injury, and (3) clinical measurements of lung function including the pulmonary dead space fraction, respiratory compliance and oxygenation in order to assess the combined predictive value of both biologic and physiologic mechanisms that contribute to impaired alveolar fluid clearance in clinical lung injury.
In Aim 3, we will use a novel preparation of ventilated and perfused human lungs harvested from brain dead donors to measure both lung endothelial and epithelial permeability and alveolar epithelial fluid clearance to test the effect of several clinically relevant therapeutic strategies (low tidal volume, high frequency ventilation, beta-2 adrenergic agonist, dopamine, interleukin-1 receptor antagonist, and inhibitors of transforming growth factor- b) on lung fluid balance over 4-8 hours. In summary, the integrated studies of biochemical, physiological and clinical measurements in critically ill patients in aim 2 will generate new insights into the mechanisms that impair alveolar epithelial fluid clearance in clinical acute lung injury. The proposed studies in aims 1 and 3 studies will provide innovative, novel approaches that use human alveolar type II cells and human lungs to study the mechanisms of alveolar epithelial injury as well as to test the potential value of several clinically relevant therapeutic strategies.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HL051856-14
Application #
7591754
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Harabin, Andrea L
Project Start
1996-04-01
Project End
2011-03-31
Budget Start
2009-04-01
Budget End
2010-03-31
Support Year
14
Fiscal Year
2009
Total Cost
$375,049
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Ross, James T; Matthay, Michael A; Harris, Hobart W (2018) Secondary peritonitis: principles of diagnosis and intervention. BMJ 361:k1407
Fielding-Singh, Vikram; Matthay, Michael A; Calfee, Carolyn S (2018) Beyond Low Tidal Volume Ventilation: Treatment Adjuncts for Severe Respiratory Failure in Acute Respiratory Distress Syndrome. Crit Care Med 46:1820-1831
Gupta, Naveen; Sinha, Ranjeet; Krasnodembskaya, Anna et al. (2018) The TLR4-PAR1 Axis Regulates Bone Marrow Mesenchymal Stromal Cell Survival and Therapeutic Capacity in Experimental Bacterial Pneumonia. Stem Cells 36:796-806
Zhao, Zhiguo; Wickersham, Nancy; Kangelaris, Kirsten N et al. (2017) External validation of a biomarker and clinical prediction model for hospital mortality in acute respiratory distress syndrome. Intensive Care Med 43:1123-1131
Matthay, Michael A; Pati, Shibani; Lee, Jae-Woo (2017) Concise Review: Mesenchymal Stem (Stromal) Cells: Biology and Preclinical Evidence for Therapeutic Potential for Organ Dysfunction Following Trauma or Sepsis. Stem Cells 35:316-324
Ding, Yan; Zhao, Runzhen; Zhao, Xiaoli et al. (2017) ENaCs as Both Effectors and Regulators of MiRNAs in Lung Epithelial Development and Regeneration. Cell Physiol Biochem 44:1120-1132
Zinter, Matt S; Orwoll, Benjamin E; Spicer, Aaron C et al. (2017) Incorporating Inflammation into Mortality Risk in Pediatric Acute Respiratory Distress Syndrome. Crit Care Med 45:858-866
Agrawal, Pankaj B; Wang, Ruobing; Li, Hongmei Lisa et al. (2017) The Epithelial Sodium Channel Is a Modifier of the Long-Term Nonprogressive Phenotype Associated with F508del CFTR Mutations. Am J Respir Cell Mol Biol 57:711-720
Matthay, Michael A; McAuley, Daniel F; Ware, Lorraine B (2017) Clinical trials in acute respiratory distress syndrome: challenges and opportunities. Lancet Respir Med 5:524-534
Laffey, John G; Matthay, Michael A (2017) Fifty Years of Research in ARDS. Cell-based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value. Am J Respir Crit Care Med 196:266-273

Showing the most recent 10 out of 162 publications